Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
What's New at Bioss?
The emergence of a novel human coronavirus, named SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Same as the SARS-CoV found in 2003, phylogenetic analysis revealed that SARS-CoV-2 also belongs to beta genus coronavirus.
Pennybody Promotion
Haven't worked with Bioss Antibodies before? Try one of our 20uL trial-sized vials for just $0.01 plus shipping. Click here to view program details and to request your discount code for this promotional pricing.
The Blog
Self-diagnosis for COVID-19With the rapid increase of coronavirus infections, many healthcare systems are almost one step away from collapse. POC tests that do not need special instruments and trained personals will dramatically help our doctors to focus more of their time on taking care of real COVID-19 patients.
Newly Announced Epitopes of SARS-CoV-2 May Facilitate the Vaccine DesignNewly published research provides the first analysis of potential targets for effective immune responses against the novel coronavirus. Researchers used existing data from known coronaviruses to predict which parts of SARS-CoV-2 are capable of activating the human immune system.
Are intermediate hosts essential to facilitate the bat-originated coronavirus hop to humans?It was considered that most of the viruses in nature are species-dependent and the cross-species transmission is not common and seems fortunate. However, recent severe outbreaks such as bird flu, Ebola fever, SARS, and COVID-19, made researchers ask whether cross-species transmission is more frequent and important than what we previously realized.
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
About Us
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.